Dr. Dijana Djureinovic

Biography

Dijana Djureinovic is an Associate Research Scientist at Yale School of Medicine specializing in immunology and oncology. She obtained her PhD from Uppsala University in the field of Immunology, Genetics, and Pathology in 2018 and holds an MSc in Biology from the same institution. Djureinovic's research primarily revolves around cancer immunotherapy, focusing on the efficacy and mechanisms of therapies targeting cancer-testis antigens and the modulation of immune responses in treatment-resistant melanoma. Her work includes conducting clinical trials involving pembrolizumab and bevacizumab for untreated melanoma brain metastases, demonstrating significant response rates and progression-free survival. Djureinovic is actively involved in collaborative research, contributing to presentations at major conferences and publishing her findings in reputable journals. She is committed to advancing cancer treatment through the exploration of immune-targeted strategies and has received several awards for her research excellence, including a travel grant to international cancer conferences and recognition for her contributions to cancer immunology.

Research Interests

Experience